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Abstract 
This article analyzes the situation of the medicine price in 
our medical industry, and the reason for the virtual high 
price of the medicine, including government regulation 
and medical insurance system defects. Then puts forward 
corresponding measures to solve the problems
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INTRODUCTION
We should improve health level and make sure everyone 
enjoys medical security. It is not only a guarantee of 
social and economic development but also an important 
goal of the construction of socialist modernization. 
According to the result of the fourth National Health 
Service survey, we can see that 14.9% of patients don’t 
seek medical help because of the economic difficulties. 
There are 70.3% of patients who need hospitalization not 
in hospital also because of “financial problems”. 36.8% 
of inpatients want to discharge, and 54.5% of them due 
to economic difficulty or spending too much. We can 
conclude that the medical cost has a great influence on 
patient; thanks to the medical expenditures burden a lot 
of patients give up treatment.
And China Health Statistical Yearbook 2012 shows that 
drug cost account for 40%-60% of the total medical cost. 
This number of OECD is 5%-20% and in Japan it is about 
20%, they are much lower than ours. So we can say the 
high drug cost is the reason for the high medical cost in our 
country.
1.  THE STATUS QUO OF DRUG PRICE
1.1  The Virtual-High Medicine Price Is One of the 
Hot Spot Problems
In recent years, the social problem of “high expense and 
difficulties in medicines” was increasingly prominent. 
The total health expenditure increased year by year. 
Although the coverage rate of various medical insurance 
has reached 80%, more than half of the medical expenditure 
were still paid by individual and the growth rate of 
medical expense grew faster than that of personal income. 
Because drug price accounts for 40%-60% of total medical 
expenditure, it became the focus of the theorists, and then 
there came from the virtual high price of the medicine. 
At the same time some examples were reported by the 
medium, many people recognized it was a terrible problem 
and it has become a common phenomenon.
1.2  The Form of Virtual High Drug Price 
1.2.1  The Drug Price Itself Is Virtual High
This is because the drug market transaction price is 
much higher than that of normal cost. In the process of 
drug from manufacturer to hospital, there are various 
distributions of interests; at last this increased part 
becomes consumer’s burden.
1.2.2  The Same Drug Has Different Prices
Due to different sellers there are different prices of one 
same drug. According to an investigation made by a 
column of CCTV, the drug price of common pharmacy is 
20%-50% higher than that of parity pharmacy and hospital 
is 30%-40% higher than common pharmacy.
1.2.3  The Price of Same Kind Drug Is Disproportionate
Pharmaceutical manufacturing or operating enterprise 
always changes the name of drug or uses other means to 
create a separate supply and demand, and then they can 
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achieve a temporary monopoly profit. Especially for the 
antibiotics, the later it comes the more expensive it is.
2.  THE REASON FOR VIRTUAL HIGH PRICE
2.1  There Are Defects In Government System
In our country we enforce additional rate control policy 
to manage drugs. Government regulates the drug’s retail 
price of public medical institutions by controlling the 
purchase price and the make-up rate of drugs. One of the 
control policies is 15% contango increase. In order to 
increase hospital income, doctors prefer the expensive 
drugs and it don’t go against the policy. So the price 
becomes abnormally high.
2.2  The Monopoly Position of Public Health 
Institution
The threshold of medical industry in our country is so 
low that there are many medical production enterprises. 
This makes medical institutions occupying the initiative 
in dealing with production enterprises. Especially for 
public health institutions, on one hand some drugs are 
only sold in them, on the other hand they take up 80% 
of the drug market; the pharmaceutical factories have to 
sell to them to enter this main market.
2.3  Health Insurance System Is Not Perfect
In our country the current medical insurance is just to 
solve the basic medical security. Due to the fixed medical 
insurance position some people can not enjoy Medicare 
reimbursement. Although the urban workers and urban 
residents’ medical insurance and the new type of rural 
cooperative medical care system are widespread, they 
don’t have a high paying level. The WHO recommends 
that personal spending should account for 15%-20% of 
the total health expenditure, but in our country the number 
is 35.5% in 2011.
2.4  The Reform of The Pharmaceutical and 
Healthcare Makes Slow Progress
“Fee for service” and “drug-maintaining-medicine” 
is two cancers of our health system. In our country 
health service price implements government’s guiding 
price which called Fee for service, but at present most 
hospital adopt the highest price of one service, this 
makes excessive medical consumption and aggravates 
patients’ financial burden. Drug-maintaining-medicine 
is the main economic compensation mechanism in 
medical institutions. Government subsidies can’t cover 
hospitals’ cost, so they proportionally increase drugs’ 
price to gain extra profit. Then the additional rate control 
policy becomes drug-maintaining-medicine. Drugs’ price 
becomes higher and higher, people are afraid to go to 
hospital.
3.  SOLUTIONS TO THE VIRTUAL HIGH PRICE
3.1  Strengthen Government Supervision
Firstly government should enhance accounting drug 
production cost and the analysis of market’s supply and 
demand. To solve the price problem fundamentally, cost 
accounting of drugs must be done well. Secondly drugs 
should be sold at mark price, in order to increase the 
transparency and further strengthen social supervision.
3.2  Improve Physic Purchase of Centralized 
Bidding
Since we implemented physic purchase of centralized 
bidding, it has made some active effects on decreasing 
drugs’ price. But according to the results of some pilot 
areas, the policy still has many defects which make the 
policy can’t fully play its active role. Therefore it should 
be improved. For example, we should improve the 
method of drugs’ purchase-sale pricing and drug bidding 
criterion; strengthen the construction of legal system and 
market supervision; rectify misconduct in drug bidding 
procurement and so on.
3.3  Break the Monopoly of Public Medical 
Institutions
The monopoly of public medical institutions is the main 
reason for selling high price drugs. They are monopoly 
both in drugs circulation and sale so they can make the 
max profit from selling drugs. And doctors can take this 
advantage to prescribe expensive drugs to further strengthen 
the induced demand. So this monopoly must be broken.
3.4  Reform the Medical Payment System
Breaking the monopoly of public medical institutions 
can force them to reduce drugs’ price, but if we don’t 
find anther way to increase their income, they will close 
down sooner or later. The old way is that the government 
increases financial subsidy. The new medical system 
reform scheme puts forward a new way which is 
increasing medical services price. This will reduce their 
dependence on drugs’ price and release the situation of 
drug-maintaining-medicine.
CONCLUSION
The rising pharmaceutical prices and medical costs are a 
worldwide problem. The virtual high price of the medicine 
is not only a problem of price, but also a problem of health 
system. It relates to the economic and social development 
stage, the market environment, the construction of legal 
system and so on. We can not expect to solve this problem 
by only a few reform measures, but we can perfectly 
prevent its spread and development. Except continuing 
to push on mechanism and system reform, there are two 
effective ways: one is the separation of dispensing from 
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prescription. The drug is mainly sold by retail drugstores, 
hospital and doctors don’t participate in the sales; the other 
one is continuing to strengthen government regulation of 
drug prices, improving the pricing method and pricing 
procedure, increasing the scientific level and transparency 
of pricing, using the macro-control means to solve market 
failure. Look forward to achieve the magnificent goal of 
reasonable control of drug prices, safeguarding people’s 
heath and public basic right of using medicines.
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